Autopsy report · NCT05282654

Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions

“Grant Terminated by Sponsor”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 years 3 months before it stopped.
• 937 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Brigham and Women's Hospital

Sponsor type

University, hospital or other

Conditions

Multiple Chronic Conditions; Adverse Event

Interventions

ePRO Application

Participants

937

Sites

2

Countries

United States

Trials that died the same way

• Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
  “Sponsor terminated financial support” (78% match in meaning)
• Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
  “Sponsor Terminated” (77% match in meaning)
• A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
  “Funding terminated” (75% match in meaning)
• MISP 60528 Pneumococcal Vaccination
  “Termination of funding by the sponsor/funder.” (75% match in meaning)
• Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma
  “Funding withdrawn by sponsor” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.